Orica – FY20 Earnings

Orica is under Algo Engine buy conditions and is a current holding in our ASX model portfolios.

ORI reported FY20 results, with EBIT of $605m, (down 9% on the same time last year), and underlying NPAT of $300m.

To support an improving share price we continue to monitor the potential for faster-than-expected resolution of manufacturing of the Burrup Plant.

FY21 dividend yield is forecast at 2.8%.

Sonic Healthcare – Buy

Sonic Healthcare is looking oversold and we believe buying support will build within the $31 – $34 price range.

SHL has a large percentage of its diagnostic equipment revenue based in US Dollars. As such, the company will benefit from the lower Aussie Dollar.